- Home
- ELSE vs BRNS Comparison
ELSE vs BRNS Comparison
Compare ELSE & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELSE | BRNS |
|---|---|---|
| Founded | 1968 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.1M | 24.1M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELSE | BRNS |
|---|---|---|
| Price | $7.71 | $0.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 5.8K | ★ 38.9K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $10,142,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.20 | N/A |
| 52 Week Low | $4.10 | $0.51 |
| 52 Week High | $7.75 | $2.91 |
Technical Indicators
Market Signals| Indicator | ELSE | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 67.54 | 52.44 |
| Support Level | $7.63 | $0.65 |
| Resistance Level | $7.75 | $0.75 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 92.31 | 62.94 |
Price Performance
Historical ComparisonAbout ELSE Electro-Sensors Inc.
Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.